These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35090965)

  • 21. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.
    Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I
    Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
    He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Micheliolide Enhances Radiosensitivities of p53-Deficient Non-Small-Cell Lung Cancer via Promoting HIF-1α Degradation.
    Kong P; Yu KN; Yang M; Almahi WA; Nie L; Chen G; Han W
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent Phenotype.
    Nilsson MB; Robichaux J; Herynk MH; Cascone T; Le X; Elamin Y; Patel S; Zhang F; Xu L; Hu L; Diao L; Shen L; He J; Yu X; Nikolinakos P; Saintigny P; Fang B; Girard L; Wang J; Minna JD; Wistuba II; Heymach JV
    J Thorac Oncol; 2021 Mar; 16(3):439-451. PubMed ID: 33309987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of monoamine oxidase A in HPV-16 E7-induced epithelial-mesenchymal transition and HIF-1α protein accumulation in non-small cell lung cancer cells.
    Huang B; Zhou Z; Liu J; Wu X; Li X; He Q; Zhang P; Tang X
    Int J Biol Sci; 2020; 16(14):2692-2703. PubMed ID: 32792865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.
    Qi L; Zhu F; Li SH; Si LB; Hu LK; Tian H
    PLoS One; 2014; 9(8):e106032. PubMed ID: 25162518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer.
    Luo F; Luo M; Rong QX; Zhang H; Chen Z; Wang F; Zhao HY; Fu LW
    J Immunother Cancer; 2019 Sep; 7(1):245. PubMed ID: 31511071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity.
    Liu C; Zheng S; Jin R; Wang X; Wang F; Zang R; Xu H; Lu Z; Huang J; Lei Y; Mao S; Wang Y; Feng X; Sun N; Wang Y; He J
    Cancer Lett; 2020 Feb; 470():95-105. PubMed ID: 31644929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR.
    Meng S; Wang G; Lu Y; Fan Z
    Lung Cancer; 2018 Jul; 121():82-90. PubMed ID: 29858032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-cell RNA sequencing reveals enhanced antitumor immunity after combined application of PD-1 inhibitor and Shenmai injection in non-small cell lung cancer.
    Yu D; Yang P; Lu X; Huang S; Liu L; Fan X
    Cell Commun Signal; 2023 Jul; 21(1):169. PubMed ID: 37430270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PD-1 blockade-unresponsive human tumor-infiltrating CD8
    Kim KH; Kim HK; Kim HD; Kim CG; Lee H; Han JW; Choi SJ; Jeong S; Jeon M; Kim H; Koh J; Ku BM; Park SH; Ahn MJ; Shin EC
    Cell Mol Immunol; 2021 Feb; 18(2):385-397. PubMed ID: 32332901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
    Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
    Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression.
    Yin X; Xia J; Sun Y; Zhang Z
    BMC Pulm Med; 2020 Feb; 20(1):40. PubMed ID: 32054470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice.
    Jacoby JJ; Erez B; Korshunova MV; Williams RR; Furutani K; Takahashi O; Kirkpatrick L; Lippman SM; Powis G; O'Reilly MS; Herbst RS
    J Thorac Oncol; 2010 Jul; 5(7):940-9. PubMed ID: 20512076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer.
    Hung JJ; Yang MH; Hsu HS; Hsu WH; Liu JS; Wu KJ
    Thorax; 2009 Dec; 64(12):1082-9. PubMed ID: 19778933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer.
    Chen YQ; Zhao CL; Li W
    J Exp Clin Cancer Res; 2009 Feb; 28(1):29. PubMed ID: 19245702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha.
    Kim WY; Oh SH; Woo JK; Hong WK; Lee HY
    Cancer Res; 2009 Feb; 69(4):1624-32. PubMed ID: 19176399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.